Showing results (2101-2110 of 2,125) with videos related to
Sort By:
Pageof 213
Journal of Chemical Theory and Computation|September 28, 2023
A Perspective on Sustainable Computational Chemistry Software Development and IntegrationRosa Di Felice, Maricris L Mayes, Ryan M Richard, et al.Journal of Chemical Theory and Computation|November 11, 2025
A Perspective on Quantum Computing Applications in Quantum Chemistry Using 25-100 Logical QubitsYuri Alexeev, Victor S Batista, Nicholas Bauman, et al.Chemical Reviews|March 31, 2021
From NWChem to NWChemEx: Evolving with the Computational Chemistry LandscapeKarol Kowalski, Raymond Bair, Nicholas P Bauman, et al.Nature Communications|February 15, 2022
Clinical and biomarker analyses of sintilimab versus chemotherapy as second-line therapy for advanced or metastatic esophageal squamous cell carcinoma: a randomized, open-label phase 2 study (ORIENT-2)Jianming Xu, Yi Li, Qingxia Fan, et al.Nucleic Acids Research|October 18, 2024
A novel interpretable deep learning-based computational framework designed synthetic enhancers with broad cross-species activityZhaohong Li, Yuanyuan Zhang, Bo Peng, et al.The Science of the Total Environment|August 5, 2024
Rapid and extensive SARS-CoV-2 Omicron variant infection wave revealed by wastewater surveillance in Shenzhen following the lifting of a strict COVID-19 strategyYinghui Li, Chen Du, Ziquan Lv, et al.Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|December 13, 2025
High-Penetrance Rare Variants Underlying Familial Lung Cancer Risk: Insights From Genetic Epidemiology of Lung Cancer ConsortiumYanhong Liu, Yafang Li, Jinyoung Byun, et al.The Journal of Chemical Physics|October 21, 2024
Electronic structure simulations in the cloud computing environmentEric J Bylaska, Ajay Panyala, Nicholas P Bauman, et al.Nature Communications|May 18, 2021
Connectivity characterization of the mouse basolateral amygdalar complexHouri Hintiryan, Ian Bowman, David L Johnson, et al.Cancer Communications (London, England)|November 7, 2022
Sintilimab versus docetaxel as second-line treatment in advanced or metastatic squamous non-small-cell lung cancer: an open-label, randomized controlled phase 3 trial (ORIENT-3)Yuankai Shi, Lin Wu, Xinmin Yu, et al.Pageof 213